Paul Streck

Teknisk/Vetenskaplig/F&U Direktör på PEPGEN INC.

Förmögenhet: 17 031 $ per 2026-05-31

62 år

Health Technology

Consumer Services

Profil

Paul D.
Streck is Executive VP, Head-Research & Development at PepGen Inc. since 2024.
Former roles include Director-Marketing at Amgen USA, Inc. (2006–2007), Chief Medical Officer at Insmed, Inc. (2017–2019), Chief Medical Officer & SVP-Clinical Development at Arena Pharmaceuticals, Inc. (2020–2022), Group Vice President at Shire Plc (2013–2015), Group Vice President at GSK Plc, Chief Medical Officer at Lundbeck Seattle BioPharmaceuticals, Inc., and Chief Medical Officer at Albireo Pharma, Inc. Education includes undergraduate studies at Rutgers State University of New Jersey, graduate studies at Sidney Kimmel Medical College, and an MBA from The Fuqua School of Business.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
PEPGEN INC. 0,02 %	2026-03-31	11 354 ( 0,02 % )	17 031 $	2026-05-31

Aktiva positioner av Paul Streck

Företag	Position	Start
PEPGEN INC.	Teknisk/Vetenskaplig/F&U Direktör	2024-08-20

Alla aktiva positioner av Paul Streck

Tidigare kända positioner av Paul Streck

Företag	Position	Slut
ARENA PHARMACEUTICALS	Teknisk/Vetenskaplig/F&U Direktör	2022-03-11
INSMED INCORPORATED	Teknisk/Vetenskaplig/F&U Direktör	2019-01-18
SHIRE	Företagsledare/Principal	2015-11-01
Amgen USA, Inc. Amgen USA, Inc. BiotechnologyHealth Technology Manufactures biological products	Försäljning & Marknadsföring	2007-10-01
ALBIREO PHARMA, INC.	Teknisk/Vetenskaplig/F&U Direktör	-

Se detaljerna i Paul Strecks erfarenhet

Paul Strecks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Paul Strecks erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	11
Insmed, Inc. Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases	Health Technology
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases	Health Technology
Sidney Kimmel Medical College Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Fuqua School of Business The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders	Health Technology
Amgen USA, Inc. Amgen USA, Inc. BiotechnologyHealth Technology Manufactures biological products	Health Technology
PepGen Inc. PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases	Health Technology